{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:47:30Z","timestamp":1759132050896,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:00:00Z","timestamp":1441670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1208\/s12249-015-0407-9","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T17:40:44Z","timestamp":1441734044000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Discriminative Dissolution Method for Benzoyl Metronidazole Oral Suspension"],"prefix":"10.1208","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-7941","authenticated-orcid":false,"given":"Aline Santos","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"da Rosa Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1vero Reisdorfer","family":"Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Ernestina Barcellos","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,8]]},"reference":[{"issue":"1","key":"407_CR1","first-page":"39","volume":"29","author":"EH Turgut","year":"2004","unstructured":"Turgut EH, \u00d6zyazici M. Bioavailability file: metronidazole. FABAD J Pharm Sci. 2004;29(1):39\u201349.","journal-title":"FABAD J Pharm Sci"},{"issue":"5-6","key":"407_CR2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s002530100720","volume":"57","author":"JC Harris","year":"2001","unstructured":"Harris JC, Plummer S, Lloyd D. Antigiardial drugs. Appl Microbiol Biotechnol. 2001;57(5-6):614\u20139.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"407_CR3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jpba.2005.02.019","volume":"38","author":"DK Bempong","year":"2005","unstructured":"Bempong DK, Manning RG, Mirza T, Bhattacharyya L. A stability-indicating HPLC assay for metronidazole benzoate. J Pharm Biomed Anal. 2005;38(4):776\u201380.","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"407_CR4","first-page":"558","volume":"12","author":"NT Vu","year":"2008","unstructured":"Vu NT, Aloumanis V, Ben MJ, Kupiec TC, Patterson EK, Radke J. Stability of metronidazole benzoate in SyrSpend SF one-step suspension system. Int J Pharm Compd. 2008;12(6):558\u201364.","journal-title":"Int J Pharm Compd"},{"issue":"2","key":"407_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2125.1982.tb01962.x","volume":"14","author":"GW Houghton","year":"1982","unstructured":"Houghton GW. A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole. Br J Clin Pharmacol. 1982;14(2):201\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"407_CR6","unstructured":"FDA. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); May 2015. http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070246.pdf"},{"key":"407_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2014.01.009","volume":"57","author":"Y Tsume","year":"2014","unstructured":"Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 2014;57:152\u201363.","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"407_CR8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/jps.24036","volume":"103","author":"GM Bredael","year":"2014","unstructured":"Bredael GM, Bowers N, Boulineau F, Hahn D. In vitro\u2013in vivo correlation strategy applied to an immediate-release solid oral dosage form with a biopharmaceutical classification system iv compound case study. J Pharm Sci. 2014;103(7):2125\u201330.","journal-title":"J Pharm Sci"},{"issue":"3","key":"407_CR9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-012-9364-3","volume":"14","author":"VS Purohit","year":"2012","unstructured":"Purohit VS. Biopharmaceutic planning in pediatric drug development. AAPS J. 2012;14(3):519\u201322.","journal-title":"AAPS J"},{"issue":"2","key":"407_CR10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1208\/s12249-010-9421-0","volume":"11","author":"L Bajerski","year":"2010","unstructured":"Bajerski L, Rossi RC, Dias CL, Bergold AM, Fr\u00f6ehlich PE. Development and validation of a discriminating in vitro dissolution method for a poorly soluble drug, olmesartan medoxomil: comparison between commercial tablets. AAPS PharmSciTech. 2010;11(2):637\u201344.","journal-title":"AAPS PharmSciTech"},{"key":"407_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","volume":"15","author":"JB Dressman","year":"1998","unstructured":"Dressman JB, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res. 1998;15:11\u201322.","journal-title":"Pharm Res"},{"issue":"2","key":"407_CR12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1208\/s12249-011-9634-x","volume":"12","author":"CK Brown","year":"2011","unstructured":"Brown CK, Friedel HD, Barker AR, Buhse LF, Keitel S, Cecil TL, et al. FIP\/AAPS joint workshop report: dissolution\/in vitro release testing of novel\/special dosage forms. AAPS PharmSciTech. 2011;12(2):782\u201394.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"407_CR13","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1208\/s12249-009-9320-4","volume":"10","author":"LB Fonseca","year":"2009","unstructured":"Fonseca LB, Labastie M, Sousa VP, Volpato NM. Development and validation of a discriminative dissolution test for nimesulide suspensions. AAPS PharmSciTech. 2009;10(4):1145\u201352.","journal-title":"AAPS PharmSciTech"},{"key":"407_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5173(88)90235-9","volume":"47","author":"M Bisrat","year":"1988","unstructured":"Bisrat M, Nystr\u00f6m C. Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions. Int J Pharm. 1988;47:223\u201331.","journal-title":"Int J Pharm"},{"key":"407_CR15","unstructured":"The United States Pharmacopeia, 36th ed., and The National Formulary, 31st ed. 36 ed. Rockville, MD: United States Pharmacopeial Convention, Inc.; 2013."},{"issue":"12","key":"407_CR16","first-page":"900","volume":"60","author":"MP Alves","year":"2005","unstructured":"Alves MP, Pohlmann AR, Guterres SS. Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization. Pharmazie. 2005;60(12):900\u20134.","journal-title":"Pharmazie"},{"issue":"2","key":"407_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14227\/DT190212P38","volume":"19","author":"MBV Priya","year":"2012","unstructured":"Priya MBV, Murthy TEGK. Development of discriminative dissolution media for marketed gliclazide modified-release tablets. Dissolut Technol. 2012;19(2):38\u201342.","journal-title":"Dissolut Technol"},{"key":"407_CR18","unstructured":"ICH, validation of analytical procedures: text and methodology (Q2R1), in International Conference on Harmonization; November 2005."},{"issue":"1","key":"407_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14227\/DT120105P22","volume":"12","author":"M Lindenberg","year":"2005","unstructured":"Lindenberg M, Wiegand C, Dressman JB. Comparison of the adsorption of several drugs to typical filter materials. Dissolut Technol. 2005;12(1):22\u20135.","journal-title":"Dissolut Technol"},{"issue":"2","key":"407_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"1-2","key":"407_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5173(00)00554-8","volume":"209","author":"N Yuksel","year":"2000","unstructured":"Yuksel N, Kan\u0131k AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int J Pharm. 2000;209(1-2):57\u201367.","journal-title":"Int J Pharm"},{"issue":"1","key":"407_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.14227\/DT210114P19","volume":"21","author":"NP Bernal","year":"2014","unstructured":"Bernal NP, Calpenal AC, Mallandrich M, Ruiz A, Clares B. Development, physical-chemical stability, and release studies of four alcohol-free spironolactone suspensions for use in pediatrics. Dissolut Technol. 2014;21(1):19\u201330.","journal-title":"Dissolut Technol"},{"issue":"2","key":"407_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-5173(83)90144-8","volume":"15","author":"A Hoelgaard","year":"1983","unstructured":"Hoelgaard A, Moller N. Hydrate formation of metronidazole benzoate in aqueous suspensions. Int J Pharm. 1983;15(2):213\u201321.","journal-title":"Int J Pharm"},{"issue":"12","key":"407_CR24","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1365-2621.2009.02088.x","volume":"44","author":"BS Roopa","year":"2009","unstructured":"Roopa BS, Bhattacharya S. Characterization and modeling of time-independent and time-dependent flow behavior of sodium alginate dispersions. Int J Food Sci Technol. 2009;44(12):2583\u20139.","journal-title":"Int J Food Sci Technol"},{"issue":"3","key":"407_CR25","first-page":"50","volume":"1","author":"B Vaghela","year":"2011","unstructured":"Vaghela B, Kayastha R, Bhatt N, Pathak N, Rathod D. Development and validation of dissolution procedures. J Appl Pharm Sci. 2011;1(3):50\u20136.","journal-title":"J Appl Pharm Sci"},{"key":"407_CR26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0731-7085(98)00011-9","volume":"17","author":"NH Anderson","year":"1998","unstructured":"Anderson NH, Bauer M, Boussac N, Khan-Malek R, Munden P, Sardaro M. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm Biomed Anal. 1998;17:811\u201322.","journal-title":"J Pharm Biomed Anal"},{"issue":"1-2","key":"407_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5173(02)00127-8","volume":"240","author":"E Adams","year":"2002","unstructured":"Adams E, Coomans D, Smeyers-Verbeke J, Massart DL. Non-linear mixed effects models for the evaluation of dissolution profiles. Int J Pharm. 2002;240(1-2):37\u201353.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"407_CR28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","volume":"309","author":"V Papadopouloi","year":"2006","unstructured":"Papadopouloi V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309(1-2):44\u201350.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-015-0407-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-015-0407-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-015-0407-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:33:25Z","timestamp":1559604805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-015-0407-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1208\/s12249-015-0407-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2015,9,8]]}}}